SavedAdd your journal

Journals / Kocatepe Veteriner Dergisi / 2018 / Cilt: 11 - Sayı: 2

CXC Chemokine Ligand 12 and G Protein-Coupled Receptor 30 Expressions in Canine Mammary Tumors of Mixed Origin

Mikst Orjinli Köpek Meme Tümörlerinde CXC Chemokine Ligand 12 ve G Protein Coupled Receptor 30 Ekspresyonları

Mehmet Eray ALÇIĞIR
Elvan ANADOL
Nilgün GÜLTİKEN
Kübra KARAKAŞ ALKAN
Hasan ALKAN
Halit KANCA
Pages
104–112
Publication Date
2018-02-14
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

There was considered to be a close relationship between mixed composition CMT and subacute inflammation, and thus it was concluded that inflammtory cells may trigger or initiate neoplastic transformation in the cellular environment including differentiated cells of the mammary gland.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Canine mammary tumors (CMT) included complex interactions in the etiopathogenesis.
📊
Key Findings & Data:The aim of this study was to reveal the roles of chemokine CXC Ligand 12 (CXCL12) and G protein coupled receptor 30 (GPCR30) expressions in the inflammatory process and neoplastic development in canine mammary glands.
💡
Conclusion & Impact:There was considered to be a close relationship between mixed composition CMT and subacute inflammation, and thus it was concluded that inflammtory cells may trigger or initiate neoplastic transformation in the cellular environment including differentiated cells of the mammary gland.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Şemoatraktif sitokin · G protein · klinikopatoloji

Abstract

Canine mammary tumors (CMT) included complex interactions in the etiopathogenesis. It is the most common problem of neoplasia in female dogs. The aim of this study was to reveal the roles of chemokine CXC Ligand 12 (CXCL12) and G protein coupled receptor 30 (GPCR30) expressions in the inflammatory process and neoplastic development in canine mammary glands. Therefore, after clinical and pathomorphological evaluation, 18 cases of mixed origin malignant forms (mixed-type carcinoma-n=6, complex-type carcinoma-n=3, carcinosarcoma-n=7, carcinoma and malignant myoepithelioma-n=2)] were examined in the study. Inflammatory cells accompanying neoplastic changes, were determined to consist of predominantly neutrophils and leukocytes, followed by lymphocytes, plasma cells and macrophages. The CXCL12 and GPCR30 expressions were scored. immunohistochemically. Most of the expressions for both markers were moderate in the mammary gland and duct epithelial cells, myoepithelial cells and inflammatory cells. Fibrocytes and fibroblasts gave a mild reaction in general, and no reaction was found in the myxoid, chondroid and osteoid matrix. There was considered to be a close relationship between mixed composition CMT and subacute inflammation, and thus it was concluded that inflammtory cells may trigger or initiate neoplastic transformation in the cellular environment including differentiated cells of the mammary gland.

Özet

Köpek meme tümörleri etiyopatogenezinde karmaşık bir seri etkileşimleri içerir. Dişi köpeklerde en yaygın karşılaşılan problemdir. Bu çalışmada, köpek meme tümörlerinde yangısal süreç ve tümör gelişimde bir çeşit chemokin olan chemokine CXC Ligand 12 (CXCL12) ile G protein coupled receptor 30 (GPCR30) ekspresyonlarının rollerini ortaya koymak amaçlandı. Bu amaçla, klinik ve patomorfolojik değerlendirmeden sonra, malignant formda mikst orjinli 18 olgu (mixed-type carcinoma-n=6, complex-type carcinoma-n=3, carcinosarcoma-n=7, carcinoma and malignant myoepithelioma-n=2) çalışmaya dahil edildi. Neoplazik değişikliklere eşlik eden yangısal hücreler ağırlıklı olarak nötrofil lökosit ve sırasıyla lenfosit, plazma hücresi ile makrofajlardan oluşuyordu. İmmunohistokimyasal olarak CXCL12 ve GPCR30 ekpsresyonları skorlandı. Her iki belirteçte ekspresyonların çoğu meme bezleri, duktal epitel hücreler, miyoepitel hücreleri ile yangısal hücrelerde orta şiddetteydi. Ancak, fibrosit ve fibroblastlarda genelde hafif şiddetteydi. Mikst orjinli köpek meme tümörleri ile subakut yangı arasında yakın bir ilişki olduğu düşünüldü. Ayrıca, yangısal hücrelerin meme bezlerinin farklılaşmasını içeren hücresel çevrenin bu mikst neoplazik dönüşümünü tetikleyebileceği veya başlatabileceği sonucuna varıldı.

🔖

Cite This Article

ALÇIĞIR, M. E., ANADOL, E., GÜLTİKEN, N., ALKAN, K. K., ALKAN, H., KANCA, H. (2018). CXC Chemokine Ligand 12 and G Protein-Coupled Receptor 30 Expressions in Canine Mammary Tumors of Mixed Origin. Kocatepe Veteriner Dergisi, Cilt: 11 - Sayı: 2, 104–112. https://ajindex.com/articles/124792

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Anadol, E., Yar Saglam, A.S., Gultiken, N., Karakas, K., Alcigir, E., Alkan, H., Kanca H. Expression of iNOS, COX-2 and VEGF in canine mammary tumours and non-neoplastic mammary glands: Association with clinicopathological features and tumour grade. Acta Vet Hung. 2017; 65(3):382-393.
  2. Boimel PJ, Smirnova T, Zhou ZN, Wyckoff J, Park H, Coniglio SJ, Qian BZ, Stanley ER, Cox D, Pollard JW, Muller WJ, Condeelis J, Segall JE. Contribution of CXCL12 secretion to invasion of breast cancer cells. Breast Cancer Res. 2012; 14:R23. Boldizsar H, Szenci O, Muray T, Csenki J. Studies on canine mammary tumours. I. Age, seasonal and breed distribution. Acta Vet Hung. 1992; 40(1-2): 75-87.
  3. Cassali GD, Lavalle GE, De Nardi AB. Consensus for the diagnosis, prognosis and treatment of canine mammary tumors. Brazil J Vet Pathol. 2011; 4(2): 153–180.
  4. Crump M, Sawka CA, DeBoer G, Buchanan RB, Ingle JN, Forbes J, Meakin JW, Shelley W, Pritchard KI. An individual patient-based meta-analysis of tamoxifen versus ovarian ablation as first line endocrine therapy for premenopausal women with metastatic breast cancer. Breast Cancer Res Treat. 1997; 44(3):201-10.
  5. Dewan MZ, Ahmed S, Iwasaki Y, Ohba K, Toi M, Yamamoto N. Stromal cell-derived factor-1 and CXCR4 receptor interaction in tumor growth and metastasis of breast cancer. Biomed Pharmacotherapy 2006; 60:273–276.
  6. Dorsam RT, Gutkind JS. G-protein-coupled receptors and cancer. Nat. Rev Cancer. 2007; 7: 79–94.
  7. Egenvall A, Bonnett BN, Ohagen P, Olson P, Hedhammar A, von Euler H. Incidence of and survival after mammary tumors in a population of over 80,000 insured female dogs in Sweden from 1995 to 2002. Prev Vet Med. 2005; 69(1-2): 109-127.
  8. Feigin ME, Xue B, Hammell MC, Muthuswamy SK. G-protein–coupled receptor GPR161 is overexpressed in breast cancer and is a promoter of cell proliferation and invasion. PNAS. 2014; 111 (11): 4191–4196.
  9. Filardo EJ, Quinn JA, Bland KI, Frackelton AR Jr. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. Mol Endocrinol. 2000; 14(10):1649-1660.
  10. Girgert R, Emons G, Gründker C. Inactivation of GPR30 reduces growth of triple-negative breast cancer cells: possible application in targeted therapy. Breast Cancer Res Treat. 2012; 134(1):199-205.
  11. Goldschmidt M, Peña L, Rasotto R, Zappulli V. Classification and grading of canine mammary tumors. Vet Pathol. 2011; 48(1):